Filing Details
- Accession Number:
- 0001209191-21-042300
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-21 20:23:07
- Reporting Period:
- 2021-06-18
- Accepted Time:
- 2021-06-21 20:23:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1662579 | C4 Therapeutics Inc. | CCCC | Biological Products, (No Disgnostic Substances) (2836) | 475617627 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1825124 | Malcolm Salter | C/O C4 Therapeutics, Inc. 490 Arsenal Way #200 Watertown MA 02472 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-06-18 | 755 | $37.19 | 14,843 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021.
Billionaire Hedge Funds
